Oncology Ventures is a venture capital firm that invests in early-stage, cancer-focused data, infrastructure, information technology, and services startups. Their strategy is to fund technologies that aim to make cancer care more affordable, efficient, and accessible, covering areas from early detection and precision diagnostics to care navigation and survivorship, while explicitly avoiding investments in drugs, medical devices, or therapeutics.
40% of their portfolio is in Cybersecurity. They made 5 investments in the last 12 months. Their most common stage is series-a (80% of deals). Average disclosed round size is $11.2M (across 4 rounds with reported amounts).
Portfolio
5
Fund Size
$30M
Top Stage
Series A
Last 12 Mo
5
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| RRISA Labs | Series A | $11.1M | Jan 2026 |
 WellBeam | Series A | $10M | Nov 2025 |
 Daymark Health | Series A | $20M | Sep 2025 |
| IIgniteData | Series A | — | Aug 2025 |
| RRISA Labs | Seed | $3.5M | Apr 2025 |
Top Co-Investors
Z21 Ventures2 shared
Cencora Ventures1 shared
Optum Ventures1 shared
FCA Venture Partners1 shared
Wittington Ventures1 shared
F-Prime Capital1 shared
Healthier Capital1 shared
Blue Venture Fund1 shared
Yosemite1 shared
Maverick Ventures1 shared
General Catalyst1 shared
Last updated: 8 March 2026